These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 12404281

  • 1. Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.
    Miki T, Mizutani Y, Nonomura N, Nomoto T, Nakao M, Saiki S, Kotake T, Okuyama A.
    Cancer; 2002 Nov 01; 95(9):1879-85. PubMed ID: 12404281
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The salvage chemotherapy for refractory testicular cancer with novel anticancer agents].
    Miki T, Nomoto T, Nakagawa S, Nakao M, Nonomura N, Takada T, Saiki S, Kotake T.
    Hinyokika Kiyo; 1999 Nov 01; 45(11):811-4. PubMed ID: 10637749
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
    Xiao H, Mazumdar M, Bajorin DF, Sarosdy M, Vlamis V, Spicer J, Ferrara J, Bosl GJ, Motzer RJ.
    J Clin Oncol; 1997 Jul 01; 15(7):2553-8. PubMed ID: 9215824
    [Abstract] [Full Text] [Related]

  • 10. Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.
    Kang HJ, Kim WS, Suh C, Park YH, Kim BS, Yuh YJ, Ryoo BY.
    Cancer Chemother Pharmacol; 2008 Jul 01; 62(2):299-304. PubMed ID: 17922274
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.
    Ilson DH.
    Oncology (Williston Park); 2004 Dec 01; 18(14 Suppl 14):22-5. PubMed ID: 15685830
    [Abstract] [Full Text] [Related]

  • 12. A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus.
    Lee DH, Kim HT, Han JY, Lee SY, Yoon SJ, Kim HY, Lee JS.
    Cancer Chemother Pharmacol; 2008 Jan 01; 61(1):83-8. PubMed ID: 17468871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Two cases of relapse or refractory germ cell tumor who had been treated with combination chemotherapy of cisplatin and carboplatin].
    Kiyama Y, Suzuki G, Masauzi N, Ohizumi H, Kobayashi N, Ogasawara M, Naohara T, Saito M, Higa T, Kasai M.
    Gan To Kagaku Ryoho; 1996 Dec 01; 23(14):1989-92. PubMed ID: 8978809
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of weekly irinotecan and cisplatin for refractory or recurrent non-small cell lung cancer.
    Takiguchi Y, Moriya T, Asaka-Amano Y, Kawashima T, Kurosu K, Tada Y, Nagao K, Kuriyama T.
    Lung Cancer; 2007 Nov 01; 58(2):253-9. PubMed ID: 17658654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study.
    Ueoka H, Tabata M, Kiura K, Shibayama T, Gemba K, Segawa Y, Chikamori K, Yonei T, Hiraki S, Harada M.
    Br J Cancer; 1999 Feb 01; 79(5-6):984-90. PubMed ID: 10070901
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.